A study published earlier this month linked Omega 3-s with the decrease in symptoms and slower progression of psychotic disorders including schizophrenia. The study followed 81 adolescents and young adults aged 13 to 25 who were at ultra-high risk of psychotic disorders; the study participants received fish oil capsules containing Omega-3 fatty acid daily for 12 weeks. After the trial period the rate of transition to psychosis was reduced and participants also experienced improvement in their symptoms and functioning. Follow ups at seven years also showed reduced rates of conversion to psychosis as well as lower scores on Positive and Negative Syndrome Scale measures, than others who had not received the medication. There is more research needed to confirm the results of this study, but as stated by William Carpenter, M.D. a professor of psychiatry and pharmacology, “If the results are valid, it will represent the most important advance related to psychosis treatment and prevention since chlorpromazine was introduced over 60 years ago.”
Click Here to read more about the study.